Department of Ophthalmology, College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
Department of Family Medicine, Korea University Ansan Hospital, Korea University College of Medicine, 123, Jeokgeum-ro, Danwon-gu, Gyeonggi-do, Ansan, Republic of Korea.
BMC Geriatr. 2021 Nov 2;21(1):620. doi: 10.1186/s12877-021-02570-7.
In the very elderly, "the lower the better" hypothesis has constantly been contradicted by randomized control trials and various cohort studies, but inconsistency in results led to unclear blood pressure treatment targets. This study aimed to assess the relationship between baseline blood pressure (BP) and ischemic stroke, myocardial infarction, and all-cause mortality in very elderly people treated for hypertension.
This large population-based retrospective cohort study was based on the national claims database of the Korean National Health Insurance System, which covers the entire Korean population. 374,250 participants aged ≥ 75 years taking antihypertensive agents were recruited, excluding patients with a history of previous ischemic stroke or myocardial infarction.
Systolic BP (SBP) followed a J curve for ischemic stroke and a U curve for all-cause mortality, with nadir ranges of 120 to 129 mmHg and 140 to 149 mmHg, respectively. While increasing diastolic BP (DBP) generally resulted in higher HRs for ischemic stroke, HRs for myocardial infarction and all-cause mortality significantly increased only when DBP was ≥ 80 mmHg and ≥ 90 mmHg, respectively. The SBP/DBP combination analysis showed that even with SBP < 130 mmHg, higher DBP ≥ 90 mmHg had higher HRs for all three outcomes compared to the reference group (130 to 149 / < 80 mmHg).
There were no further benefits or even harm below certain BP levels for ischemic stroke, myocardial infarction, and all-cause mortality in very elderly hypertensive patients.
在非常高龄的人群中,“越低越好”的假设不断受到随机对照试验和各种队列研究的反驳,但结果的不一致导致血压治疗目标不明确。本研究旨在评估基线血压(BP)与高血压治疗的非常高龄人群中缺血性卒中、心肌梗死和全因死亡率之间的关系。
这是一项基于韩国国家健康保险系统全国索赔数据库的大型基于人群的回顾性队列研究,该数据库覆盖了整个韩国人口。共招募了 374,250 名年龄≥75 岁、服用抗高血压药物的参与者,排除了有既往缺血性卒中和心肌梗死病史的患者。
收缩压(SBP)与缺血性卒中和全因死亡率呈 J 型和 U 型曲线,最低范围分别为 120-129mmHg 和 140-149mmHg。虽然舒张压(DBP)升高通常会导致缺血性卒中的 HR 升高,但只有当 DBP≥80mmHg 和≥90mmHg 时,心肌梗死和全因死亡率的 HR 才会显著升高。SBP/DBP 联合分析显示,即使 SBP<130mmHg,与参考组(130-149/ <80mmHg)相比,更高的 DBP≥90mmHg 与所有三种结局的 HR 更高。
对于非常高龄的高血压患者,在某些血压水平以下,缺血性卒中和心肌梗死及全因死亡率没有进一步的获益,甚至可能有害。